Current landscape of therapeutic resistance in lung cancer and promising strategies to overcome resistance

A Ashrafi, Z Akter, P Modareszadeh, P Modareszadeh… - Cancers, 2022 - mdpi.com
… mechanisms of therapeutic resistance is important in … lung cancer patients. In this review,
we discuss the mechanisms underlying the acquisition of resistance to different lines of therapy

Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer

H Willers, CG Azzoli, WL Santivasi, F Xia - The Cancer Journal, 2013 - journals.lww.com
… of human cancers including lung cancer. Defects … lung tumors to radiation therapy. Here,
we will review clinically relevant mechanisms affecting resistance and sensitivity of lung cancer

Drug resistance to targeted therapeutic strategies in non-small cell lung cancer

W Liu, Y Du, R Wen, M Yang, J Xu - Pharmacology & therapeutics, 2020 - Elsevier
resistance mechanisms in NSCLC targeted therapies, namely changes in the targeted
oncogenes (on-target resistance) … Therapeutic resistance limits the clinical use of chemotherapy …

Resisting resistance: targeted therapies in lung cancer

JJ Lin, AT Shaw - Trends in cancer, 2016 - cell.com
… heterogeneous nature of TKI resistance, which evolves dynamically with changes in therapy.
In this … the diverse mechanisms of resistance at play in oncogene-driven lung cancers. …

Novel third-generation EGFR tyrosine kinase inhibitors and strategies to overcome therapeutic resistance in lung cancer

A Murtuza, A Bulbul, JP Shen, P Keshavarzian… - Cancer Research, 2019 - AACR
… % of patients with non–small cell lung cancer. Tyrosine kinase inhibitors have provided an
… in cancer and the role of tumor-specific adaptations conferring therapeutic resistance. The …

Therapeutic resistance in lung cancer

A Nadkar, C Pungaliya, K Drake, E Zajac… - Expert Opinion on …, 2006 - Taylor & Francis
therapy of lung cancer, intrinsic and acquired resistance to … of mechanisms of therapeutic
resistance in lung cancer has … the crucial role of stress resistance pathways is increasingly …

A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay

AS Doghish, A Ismail, MA Elrebehy… - … -Research and Practice, 2022 - Elsevier
Lung cancer (LC) is one of the most frequently diagnosed malignancies and the leading
cause of cancer-related deaths in … Drug resistance has become a significant impediment to the …

Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistance

F Sun, L Li, P Yan, J Zhou, SD Shapiro, G Xiao… - Nature …, 2019 - nature.com
… for lung cancer therapeutic responses. While PDLIM2 is epigenetically repressed in human
lung cancer, associating with therapeutic resistance and poor prognosis, its global or lung

Drug resistance in lung cancer

M Shanker, D Willcutts, JA Roth… - Lung Cancer: Targets …, 2010 - Taylor & Francis
resistance in lung cancer. Non-small cell lung cancer (NSCLC) cells are often intrinsically
resistant … , whereas small-cell lung cancer (SCLC) cells can acquire resistance with continued …

Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy

ZF Lim, PC Ma - Journal of hematology & oncology, 2019 - Springer
… drug resistance. We attempt to summarize the gap in knowledge in understanding acquired
resistance to early-phase lung cancer targeted therapy … and early adaptive drug resistance. …